Adamis Pharmaceuticals | ADMP - Attività Correnti



Attività Correnti Cambiamento Data
Adma Biologics USD 466.51M 63.86M 2025-12
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Brainstorm Cell Therapeutics USD 307K 201K 2025-12
Cara Therapeutics USD 38.44M 4.69M 2025-09
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Merck USD 47.56B 10.49B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
RedHill Biopharma USD 12.56M 644K 2025-06